scholarly journals Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID‐19 patients.

2021 ◽  
Author(s):  
Miguel Angel Duarte Millán ◽  
Nieves Mesa Plaza ◽  
Marta Guerrero Santillán ◽  
Alejandro Morales Ortega ◽  
David Bernal Bello ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Combined Use ◽  
Spanish Cohort

495P Clinical characteristics, prognostic factors and survival of early-onset colorectal cancer (EOCRC) in a Spanish cohort

2021 ◽  
Vol 32 ◽  
pp. S575-S576
Author(s):  
J. Soto Alsar ◽  
N. Gutiérrez Alonso ◽  
M. Bringas Beranek ◽  
C. López Jiménez ◽  
A. Gutiérrez Ortiz de la Tabla ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Prognostic Factors ◽  
Early Onset ◽  
Clinical Characteristics ◽  
Early Onset Colorectal Cancer ◽  
Spanish Cohort

Prognostic factors in advanced gastric cancer after second-line treatment.

2015 ◽  
Vol 33 (3_suppl) ◽  
pp. 201-201
Author(s):  
FEDERICO LONGO ◽  
Vanessa Pachon ◽  
Carmen Guillen ◽  
Reyes Ferreiro ◽  
Mercedes Rodriguez Garrote ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Prognostic Factors ◽  
Prognostic Factor ◽  
Advanced Gastric Cancer ◽  
Primary Tumor ◽  
Female Gender ◽  
Clinical Parameters ◽  
Second Line ◽  
Treatment Administration ◽  
Spanish Cohort

201 Background: Advanced gastric cancer (AGC) is a highly lethal disease worldwide with a median overall survival (OS) of less than 12 months. Ramucirumab was the first targeted agent to show survival benefit in the second-line (2L) treatment of AGD. From the REGARD trial, women exhibited a trend towards a worse survival when compared to men. Methods: We retrospectively analyzed the outcome of a Spanish cohort of 55 AGC patients who had received at least two consecutive chemotherapy lines of treatment at our institution. We preselected some clinical parameters (age, gender, Lauren subtype, Her-2 status, grade of differentiation, primary tumor localization and resection, TNM stage, neoadjuvant/adjuvant administration, mono/polychemotherapy in 2L, irinotecan- or taxane-based 2L, Trastuzumab treatment, and administration of third-lines [3L]) to be tested as potential prognostic factors. We focused our analysis on the gender effect in OS after 2L treatment in AGC. The SPSS software package was used for all statistical analyses (Mann-Whitney U test, Chi Square, Kaplan-Meier, Cox regression). Results: Women, diffuse subtype, poorly differentiated tumors, sub-cardia location, single-agent 2L and 3L administration were the clinical characteristics with a significant shorter OS by the univariable analysis. Median OS of women (5 months, 95%CI 3.9-6.0) was significant lower than that in men (13 months, 95%CI 7.9-18.0) by both Log-Rank and Breslow tests (p 0.002). We found no significant differences in age, progression-free survival or time-on-treatment between men and women. Female gender was significantly associated with more taxane-based 2L and with less 3L treatment administration. When 3L treatment administration was excluded in the multivariable analysis, female gender was the only independent prognostic factor of all the clinical parameters included in our review (HR 0.33, 95%CI 0.15-0.75, p 0.008). Conclusions: Our retrospective study found that gender, Lauren subtype, grade of differentiation, primary tumor location, polychemotherapy and 3L administration may be potential prognostic factors in AGC after 2L treatment. Female gender was an independent prognostic factor in our Spanish cohort.

Prognostic value of [15O]H2O positron emission tomography-derived global and regional myocardial perfusion

2019 ◽  
Vol 21 (7) ◽  
pp. 777-786 ◽  
Author(s):  
Michiel J Bom ◽  
Pepijn A van Diemen ◽  
Roel S Driessen ◽  
Henk Everaars ◽  
Stefan P Schumacher ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Prognostic Factors ◽  
Prognostic Factor ◽  
Prognostic Value ◽  
Clinical Characteristics ◽  
Regional Perfusion ◽  
Emission Tomography ◽  
Prognostic Performance ◽  
Positron Emission ◽  
Combined Use

Abstract Aims To evaluate the prognostic value of global and regional quantitative [15O]H2O positron emission tomography (PET) perfusion. Methods and results In this retrospective study, 648 patients with suspected or known coronary artery disease (CAD) who underwent [15O]H2O PET were followed for the occurrence of death and myocardial infarction (MI). Global and regional hyperaemic myocardial blood flow (hMBF) and coronary flow reserve (CFR) were obtained from [15O]H2O PET. During median follow-up of 6.9 (5.0–7.9) years, 64 (9.9%) patients experienced the composite of death (36–5.6%) and MI (28–4.3%). Impaired global hMBF (<2.65 mL/min/g) and CFR (<2.88) were both significant prognostic factors for death/MI after adjusting for clinical characteristics (both P < 0.001). However, after adjusting for clinical parameters and the combined use of hMBF and CFR, only hMBF remained an independent prognostic factor (P = 0.04). For regional perfusion, both impaired hMBF (<2.10 mL/min/g) and CFR (<2.07) demonstrated prognostic value for events (both P < 0.001). Similarly, after adjusting for clinical characteristics and combined use of hMBF and CFR, only hMBF had independent prognostic value (P = 0.04). The combination of global and regional perfusion did not improve prognostic performance over either global (P = 0.55) or regional perfusion (P = 0.37) alone. Conclusion Global and regional hMBF and CFR were all prognostic factors for death and MI. However, for both global and regional perfusion, hMBF remained the only independent prognostic factor after adjusting for the combined use of hMBF and CFR. Additionally, integrating global and regional perfusion did not increase prognostic performance compared to either regional or global perfusion alone.

scholarly journals Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum

2021 ◽  
Author(s):  
Meng Cui ◽  
Hewen Chen ◽  
Guochen Sun ◽  
Jialin Liu ◽  
Meng Zhang ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Corpus Callosum ◽  
Progression Free Survival ◽  
Extent Of Resection ◽  
Conventional Approach ◽  
Conventional Group ◽  
Motor Deficits ◽  
Patient Demographics ◽  
Combined Use ◽  
Postoperative Radiochemotherapy

Abstract Purpose To compare the multimodal techniques (including neuronavigation, intraoperative MRI [iMRI], and neuromonitoring [IONM]) and conventional approach (only guided by neuronavigation) in removing glioblastoma (GBM) with corpus callosum (CC) involvement (ccGBM), their effectiveness and safety were analyzed and compared. Methods Electronic medical records were retrospectively reviewed for ccGBM cases treated in our hospital between January 2016 and July 2020. Patient demographics, tumor characteristics, clinical outcomes, extent of resection (EOR), progression-free survival (PFS), and overall survival (OS) were obtained and compared between the multimodal group (used multimodal techniques) and the conventional group (only used neuronavigation). Both groups only included patients that had maximal safe resection (not biopsy). Postoperative radiochemotherapy was also performed or not. Univariate and multivariate analyses were performed to identify significant prognostic factors and optimal EOR threshold. Results Finally 56 cases of the multimodal group and 21 cases of the conventional group were included. The multimodal group achieved a higher median EOR (100% versus 96.1%, P = 0.036) and gross total resection rate (60.7% versus 33.3%, P = 0.032) and a lower rate of permanent motor deficits (5.4% versus 23.8%, P = 0.052) than the conventional approach. The multimodal group had the longer median PFS (10.9 versus 7.0 months, P = 0.023) and OS (16.1 versus 11.6 months, P = 0.044) than the conventional group. Postoperative language and cognitive function were similar between the two groups. In multivariate analysis, a higher EOR, radiotherapy, and longer cycles of temozolomide chemotherapy were positive prognostic factors for survival of ccGBM. An optimal EOR threshold of 92% was found to significantly benefit the PFS (HR = 0.51, P = 0.036) and OS (HR = 0.49, P = 0.025) of ccGBM. Conclusion Combined use of multimodal techniques can optimize the safe removal of ccGBM. Aggressive resection of EOR > 92% using multimodal techniques combined with postoperative radiochemotherapy should be suggested for ccGBM.

Prognostic Factors in Breast Cancer

1989 ◽  
Vol 3 (4) ◽  
pp. 641-652 ◽  
Author(s):  
Douglas E. Merkel ◽  
C. Kent Osborne
Keyword(s):  
Breast Cancer ◽  
Prognostic Factors

Abstract #1059 Prognostic Factors of Metastatic Thyroid Carcinoma: A Single Center Retrospective Study

2018 ◽  
Vol 24 ◽  
pp. 249
Author(s):  
David Broome ◽  
Gauri Bhuchar ◽  
Ehsan Fayazzadeh ◽  
James Bena ◽  
Christian Nasr
Keyword(s):  
Prognostic Factors ◽  
Retrospective Study ◽  
Thyroid Carcinoma ◽  
Single Center
Sign in / Sign up

Export Citation Format

Share Document